Researchers at the University of Kentucky have discovered new biological processes by which mutations in the FUS gene cause neurodegeneration in amyotrophic lateral sclerosis (ALS).
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, announced that University of Kentucky's Matthew Gentry has received the Landis Award for Outstanding Mentorship.
Two studies from Ai-Ling Lin's lab in the Sanders-Brown Center on Aging demonstrate the effect of diet — specifically the Ketogenic diet and simple caloric restriction — on cognitive health in animals.
The Kentucky Neuroscience Clinical-Translational Research Symposium will provide basic, translational and clinical neuroscience investigators an opportunity to discuss their work, share progress and develop collaborations.
Results from a survey of more than 1,000 U.S. adults showed that while almost 80 percent of respondents were willing to volunteer for medical research, two-thirds didn't know how to get involved.
A UK neurologist who stumbled across a family with a gene mutation that can cause Lou Gehrig's Disease is merging science, medicine and family in a quest for a cure.
STAT News, a division of the Boston Globe, has published a story about the work of Dr. Edward Kasarskis and his team, who study a familial form of ALS.
A rare, genetic type of ALS seems to cluster in central Appalachia. The TRANSLATE clinical trial, led by a multidisciplinary time of clinicians and scientists, is looking for hope in an existing FDA-approved drug.
New findings from the University of Kentucky published in the Journal of Neuroscience demonstrate that there may be ways to address blood-brain barrier dysfunction in epilepsy.
